Der Algorithmische Biologe: Die Morgendämmerung der personalisierten Medizin

Within the next 15 years, AI-driven drug discovery and personalized medicine will become the norm, significantly reducing reliance on traditional clinical trials. This will manifest in the widespread use of AI algorithms that analyze individual genetic profiles to predict disease risk and tailor preventative and therapeutic strategies, leading to a dramatic shift in healthcare outcomes and lifespan. The result will be a more proactive and efficient healthcare system, with treatments designed for the unique needs of each patient.